Lataa...
Appropriateness of Dabigatran and Rivaroxaban Prescribing for Hospital Inpatients
BACKGROUND: Recent approval of the new oral anticoagulants dabigatran and rivaroxaban has led to rapid changes in anticoagulant prescribing practices. Postmarketing reports have highlighted safety concerns with these agents, and their use outside of evidence-based recommendations was noted at the au...
Tallennettuna:
| Julkaisussa: | Can J Hosp Pharm |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Canadian Society of Hospital Pharmacists
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4924939/ https://ncbi.nlm.nih.gov/pubmed/27402998 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|